Hims & Hers Health (HIMS) EBIT Margin (2020 - 2026)

Hims & Hers Health has disclosed EBIT Margin across 7 years of filings, most recently posting 12.88% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 12.88%, down 2276.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.29% (down 745.0% YoY), and the FY2025 annual result was 4.5%, up 31.0% from the prior year.
• EBIT Margin came in at 12.88% for Q1 2026 at Hims & Hers Health, down from 1.49% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 9.88% in Q1 2025 to a low of 17.78% in Q2 2022.
• The 5-year median for EBIT Margin is 0.16% (2023), against an average of 2.8%.
• Across the five-year window, EBIT Margin jumped 7584 bps in 2022 and slumped 2276 bps in 2026, its largest moves.
• Hims & Hers Health's EBIT Margin stood at 6.94% in 2022, then soared by 98 bps to 0.16% in 2023, then surged by 2483 bps to 3.86% in 2024, then sank by 62 bps to 1.49% in 2025, then slumped by 966 bps to 12.88% in 2026.
• The last three EBIT Margin figures came in at 12.88% (Q1 2026), 1.49% (Q4 2025), and 1.97% (Q3 2025), per Business Quant data.